Page last updated: 2024-09-03

pramipexole and 1-anilino-8-naphthalenesulfonate

pramipexole has been researched along with 1-anilino-8-naphthalenesulfonate in 1 studies

Compound Research Comparison

Studies
(pramipexole)
Trials
(pramipexole)
Recent Studies (post-2010)
(pramipexole)
Studies
(1-anilino-8-naphthalenesulfonate)
Trials
(1-anilino-8-naphthalenesulfonate)
Recent Studies (post-2010) (1-anilino-8-naphthalenesulfonate)
1,10321951724,2754807,815

Protein Interaction Comparison

ProteinTaxonomypramipexole (IC50)1-anilino-8-naphthalenesulfonate (IC50)
Chain A, RNA-directed RNA polymerase NS5Dengue virus 2 16681-PDK53100
Mitogen-activated protein kinase 14Homo sapiens (human)1.2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Fawzy, HA; Fawzy, HM; Fikry, EM; Mohammed, AA1

Other Studies

1 other study(ies) available for pramipexole and 1-anilino-8-naphthalenesulfonate

ArticleYear
Reorienting of pramipexole as a promising therapy for acute pancreatitis in a rat model by suppressing TLR4\\NF-κB p65\\NLRP3 inflammasome signaling.
    Canadian journal of physiology and pharmacology, 2022, Jun-01, Volume: 100, Issue:6

    Topics: Acute Disease; Amylases; Animals; Anti-Inflammatory Agents; Arginine; Inflammasomes; Lipase; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Pancreatitis; Pramipexole; Rats; Toll-Like Receptor 4

2022